Evidence map›Paper›PMID 38642908›Full record

ArticleThe oncologist2024

Delays in presentation, diagnosis, and treatment in Sudanese women with breast cancer: a cross-sectional study.

Esraa S A Alfadul, Badria Tebaig, Salma S Alrawa, Ammar Tarig Elgadi, Ensaf E M A Margani, Maab E B Adam, Mawaheb Sh Adem Mohamoud, Safa A M Elhassan, Moawia Mohammed Ali Elhassan

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in The oncologist, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Factors associated with late diagnosis of breast cancer among women in Botswana.African journal of primary health care & family medicine · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Esraa S A AlfadulFaculty of Medicine, University of Khartoum, Khartoum, Sudan.ORCID 0000-0001-9812-5095
Badria TebaigFaculty of Medicine, University of Khartoum, Khartoum, Sudan.ORCID 0009-0000-7221-7207
Salma S AlrawaFaculty of Medicine, University of Khartoum, Khartoum, Sudan.ORCID 0000-0001-8363-142X
Ammar Tarig ElgadiFaculty of Medicine, University of Khartoum, Khartoum, Sudan.ORCID 0000-0003-1730-9023
Ensaf E M A MarganiStation of Medical Essentials (SOME) Institution, Khartoum, Sudan.
Maab E B AdamStation of Medical Essentials (SOME) Institution, Khartoum, Sudan.
Mawaheb Sh Adem MohamoudStation of Medical Essentials (SOME) Institution, Khartoum, Sudan.
Safa A M ElhassanStation of Medical Essentials (SOME) Institution, Khartoum, Sudan.
Moawia Mohammed Ali ElhassanDepartment of Oncology, National Cancer Institute, University of Gezira, Wad Madani, Sudan.ORCID 0000-0002-0595-5186
University of Khartoum · SDAlMughtaribeen University · SDNahda College · SDOmdurman Islamic University · SDSinnar University · SDUniversity of Gezira · SD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe poor prognosis of breast cancer in Sudan could be due to delayed treatment and diagnosis at an advanced stage. Our study aimed to assess the extent of delays from onset of symptoms to treatment in Sudanese women with breast cancer, as well as identify factors contributing to these delays. MATERIALS AND

methodsWe conducted a multi-center cross sectional study between March and April 2023. Data were collected from the medical records and interviews with women with breast cancer in the two main oncology centers in Sudan. Linear regression was used to identify the predictors of delayed presentation.

resultsWe interviewed 601 women with breast cancer. The majority of women (50.1%) were diagnosed at locally advanced or metastatic disease. The median interval from the onset of symptoms to receiving oncologic treatment was 221 days (IQR = 92, 496). The longest delay was the presentation delay 61 (31 244) days. The median duration for diagnosis delay and treatment delay was 21 (10.57) days and 27 (10.64) days, respectively. Predictors of early presentation included, being young (β = -5.3; 95% CI = 0.06 to 10), married (β = -264; 95% CI = -427 to -101), divorced (β = -306; 95% CI = -549 to -63), or widowed (β = -320; 95% CI = --543 to -97), urban residence (β = -107; 95% CI = -213 to -2.3), and seeking traditional healer (β = -204; 95% CI = -383 to -26).

conclusionMost Sudanese women with breast cancer experience significant patient delays, often presenting at advanced stages. Factors like being single, older, and living in rural areas contribute to these delays. Increasing breast cancer education, improving healthcare access and addressing sociodemographic barriers can potentially expedite diagnosis and improve outcomes.

Indexed as

Breast NeoplasmsDelayed DiagnosisTime-to-TreatmentAdultAgedCross-Sectional StudiesFemaleHumansMiddle AgedSudanAfricabreast cancerdiagnosis and treatment intervalearly detectionlow- and middle-income countriespredictors of delay

Identifiers

PMID38642908
PMCPMC11144982
OpenAlexW4394975614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.